Clinical Trials for Myriad Genetics

Explore 5 clinical trials worldwide

Showing 1-5 of 5 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Myriad Genetics

Clinical Trials (5)

NCT05642780
SKB264 in Combination With Pembrolizumab in Subjects With Selected Solid Tumors
PHASE2Active, not recruiting
240 participants
Started: Jan 17, 2023 · Completed: Dec 31, 2027
1 condition6 sponsors48 locations
NCT05457257
Clinical Study to Assess the Efficacy and Safety of Olaparib in Chinese Patients With Metastatic Castration-Resistant Prostate Cancer Who Have Failed Prior Treatment With a New Hormonal Agent and Have BRCA1/2 Mutations
PHASE4Active, not recruiting
43 participants
Started: Jul 29, 2022 · Completed: Sep 30, 2025
1 condition4 sponsors35 locations
NCT04150042
SHARON: A Clinical Trial for Metastatic Cancer With a BRCA or PALB2 Mutation Using Chemotherapy and Patients' Own Stem Cells
PHASE1Recruiting
10 participants
Started: Jan 13, 2021 · Completed: Aug 31, 2027
15 conditions2 sponsors2 locations
NCT04245176
Genetic Testing for All Breast Cancer Patients (GET FACTS)
NAActive, not recruiting
400 participants
Started: Jan 31, 2020 · Completed: Dec 1, 2025
4 conditions2 sponsors1 location
NCT02655016
A Study of Niraparib (GSK3985771) Maintenance Treatment in Participants With Advanced Ovarian Cancer Following Response on Front-Line Platinum-Based Chemotherapy
PHASE3Active, not recruiting
733 participants
Started: Jul 11, 2016 · Completed: Jan 30, 2026
1 condition4 sponsors200 locations